Global Immuno-oncology Drugs Market Insights and Forecast to 2028

Report ID: 1802452 | Published Date: Jan 2025 | No. of Page: 125 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Immuno-oncology Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Immuno-oncology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Immune Checkpoint Inhibitors
        1.2.3 Immune System Modulators
        1.2.4 Cancer Vaccines
        1.2.5 Oncolytic Virus
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Immuno-oncology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Immuno-oncology Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Immuno-oncology Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Immuno-oncology Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Immuno-oncology Drugs Sales by Region
        2.4.1 Global Immuno-oncology Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Immuno-oncology Drugs by Region (2023-2028)
    2.5 Global Immuno-oncology Drugs Revenue by Region
        2.5.1 Global Immuno-oncology Drugs Revenue by Region (2017-2022)
        2.5.2 Global Immuno-oncology Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Immuno-oncology Drugs Sales by Manufacturers
        3.1.1 Global Top Immuno-oncology Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Immuno-oncology Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immuno-oncology Drugs in 2021
    3.2 Global Immuno-oncology Drugs Revenue by Manufacturers
        3.2.1 Global Immuno-oncology Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Immuno-oncology Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Immuno-oncology Drugs Revenue in 2021
    3.3 Global Immuno-oncology Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Immuno-oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Immuno-oncology Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Immuno-oncology Drugs Sales by Type
        4.1.1 Global Immuno-oncology Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Immuno-oncology Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Immuno-oncology Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Immuno-oncology Drugs Revenue by Type
        4.2.1 Global Immuno-oncology Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Immuno-oncology Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Immuno-oncology Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Immuno-oncology Drugs Price by Type
        4.3.1 Global Immuno-oncology Drugs Price by Type (2017-2022)
        4.3.2 Global Immuno-oncology Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Immuno-oncology Drugs Sales by Application
        5.1.1 Global Immuno-oncology Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Immuno-oncology Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Immuno-oncology Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Immuno-oncology Drugs Revenue by Application
        5.2.1 Global Immuno-oncology Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Immuno-oncology Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Immuno-oncology Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Immuno-oncology Drugs Price by Application
        5.3.1 Global Immuno-oncology Drugs Price by Application (2017-2022)
        5.3.2 Global Immuno-oncology Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Immuno-oncology Drugs Market Size by Type
        6.1.1 North America Immuno-oncology Drugs Sales by Type (2017-2028)
        6.1.2 North America Immuno-oncology Drugs Revenue by Type (2017-2028)
    6.2 North America Immuno-oncology Drugs Market Size by Application
        6.2.1 North America Immuno-oncology Drugs Sales by Application (2017-2028)
        6.2.2 North America Immuno-oncology Drugs Revenue by Application (2017-2028)
    6.3 North America Immuno-oncology Drugs Market Size by Country
        6.3.1 North America Immuno-oncology Drugs Sales by Country (2017-2028)
        6.3.2 North America Immuno-oncology Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Immuno-oncology Drugs Market Size by Type
        7.1.1 Europe Immuno-oncology Drugs Sales by Type (2017-2028)
        7.1.2 Europe Immuno-oncology Drugs Revenue by Type (2017-2028)
    7.2 Europe Immuno-oncology Drugs Market Size by Application
        7.2.1 Europe Immuno-oncology Drugs Sales by Application (2017-2028)
        7.2.2 Europe Immuno-oncology Drugs Revenue by Application (2017-2028)
    7.3 Europe Immuno-oncology Drugs Market Size by Country
        7.3.1 Europe Immuno-oncology Drugs Sales by Country (2017-2028)
        7.3.2 Europe Immuno-oncology Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Immuno-oncology Drugs Market Size by Type
        8.1.1 Asia Pacific Immuno-oncology Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Immuno-oncology Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Immuno-oncology Drugs Market Size by Application
        8.2.1 Asia Pacific Immuno-oncology Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Immuno-oncology Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Immuno-oncology Drugs Market Size by Region
        8.3.1 Asia Pacific Immuno-oncology Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Immuno-oncology Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Immuno-oncology Drugs Market Size by Type
        9.1.1 Latin America Immuno-oncology Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Immuno-oncology Drugs Revenue by Type (2017-2028)
    9.2 Latin America Immuno-oncology Drugs Market Size by Application
        9.2.1 Latin America Immuno-oncology Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Immuno-oncology Drugs Revenue by Application (2017-2028)
    9.3 Latin America Immuno-oncology Drugs Market Size by Country
        9.3.1 Latin America Immuno-oncology Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Immuno-oncology Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Immuno-oncology Drugs Market Size by Type
        10.1.1 Middle East and Africa Immuno-oncology Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Immuno-oncology Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Immuno-oncology Drugs Market Size by Application
        10.2.1 Middle East and Africa Immuno-oncology Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Immuno-oncology Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Immuno-oncology Drugs Market Size by Country
        10.3.1 Middle East and Africa Immuno-oncology Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Immuno-oncology Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Amgen, Inc
        11.1.1 Amgen, Inc Corporation Information
        11.1.2 Amgen, Inc Overview
        11.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Amgen, Inc Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Amgen, Inc Recent Developments
    11.2 AstraZeneca, Plc
        11.2.1 AstraZeneca, Plc Corporation Information
        11.2.2 AstraZeneca, Plc Overview
        11.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 AstraZeneca, Plc Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 AstraZeneca, Plc Recent Developments
    11.3 Bristol-Myers Squibb
        11.3.1 Bristol-Myers Squibb Corporation Information
        11.3.2 Bristol-Myers Squibb Overview
        11.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bristol-Myers Squibb Recent Developments
    11.4 Celgene Corporation
        11.4.1 Celgene Corporation Corporation Information
        11.4.2 Celgene Corporation Overview
        11.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Celgene Corporation Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Celgene Corporation Recent Developments
    11.5 Eli Lilly and Company
        11.5.1 Eli Lilly and Company Corporation Information
        11.5.2 Eli Lilly and Company Overview
        11.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Eli Lilly and Company Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Eli Lilly and Company Recent Developments
    11.6 Merck & Co.
        11.6.1 Merck & Co. Corporation Information
        11.6.2 Merck & Co. Overview
        11.6.3 Merck & Co. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Merck & Co. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Merck & Co. Recent Developments
    11.7 Hoffmann-La Roche AG
        11.7.1 Hoffmann-La Roche AG Corporation Information
        11.7.2 Hoffmann-La Roche AG Overview
        11.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Hoffmann-La Roche AG Recent Developments
    11.8 Johnson & Johnson
        11.8.1 Johnson & Johnson Corporation Information
        11.8.2 Johnson & Johnson Overview
        11.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Johnson & Johnson Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Johnson & Johnson Recent Developments
    11.9 Novartis International AG
        11.9.1 Novartis International AG Corporation Information
        11.9.2 Novartis International AG Overview
        11.9.3 Novartis International AG Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Novartis International AG Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Novartis International AG Recent Developments
    11.10 AbbVie, Inc.
        11.10.1 AbbVie, Inc. Corporation Information
        11.10.2 AbbVie, Inc. Overview
        11.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 AbbVie, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 AbbVie, Inc. Recent Developments
    11.11 Pfizer Inc.
        11.11.1 Pfizer Inc. Corporation Information
        11.11.2 Pfizer Inc. Overview
        11.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Pfizer Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Pfizer Inc. Recent Developments
    11.12 Sanofi S.A.
        11.12.1 Sanofi S.A. Corporation Information
        11.12.2 Sanofi S.A. Overview
        11.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Sanofi S.A. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Sanofi S.A. Recent Developments
    11.13 EMD Serono, Inc.
        11.13.1 EMD Serono, Inc. Corporation Information
        11.13.2 EMD Serono, Inc. Overview
        11.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 EMD Serono, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 EMD Serono, Inc. Recent Developments
    11.14 Gilead Sciences Inc.
        11.14.1 Gilead Sciences Inc. Corporation Information
        11.14.2 Gilead Sciences Inc. Overview
        11.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Gilead Sciences Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Gilead Sciences Inc. Recent Developments
    11.15 Prometheus Therapeutics & Diagnostics
        11.15.1 Prometheus Therapeutics & Diagnostics Corporation Information
        11.15.2 Prometheus Therapeutics & Diagnostics Overview
        11.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Prometheus Therapeutics & Diagnostics Recent Developments
    11.16 Aduro BioTech
        11.16.1 Aduro BioTech Corporation Information
        11.16.2 Aduro BioTech Overview
        11.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Aduro BioTech Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Aduro BioTech Recent Developments
    11.17 Galena Biopharma
        11.17.1 Galena Biopharma Corporation Information
        11.17.2 Galena Biopharma Overview
        11.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Galena Biopharma Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Galena Biopharma Recent Developments
    11.18 Bavarian Nordic
        11.18.1 Bavarian Nordic Corporation Information
        11.18.2 Bavarian Nordic Overview
        11.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.18.4 Bavarian Nordic Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Bavarian Nordic Recent Developments
    11.19 Celldex Therapeutics
        11.19.1 Celldex Therapeutics Corporation Information
        11.19.2 Celldex Therapeutics Overview
        11.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.19.4 Celldex Therapeutics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 Celldex Therapeutics Recent Developments
    11.20 ImmunoCellular Therapeutics
        11.20.1 ImmunoCellular Therapeutics Corporation Information
        11.20.2 ImmunoCellular Therapeutics Overview
        11.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.20.4 ImmunoCellular Therapeutics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.20.5 ImmunoCellular Therapeutics Recent Developments
    11.21 Incyte
        11.21.1 Incyte Corporation Information
        11.21.2 Incyte Overview
        11.21.3 Incyte Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.21.4 Incyte Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.21.5 Incyte Recent Developments
    11.22 Dendreon Corporation
        11.22.1 Dendreon Corporation Corporation Information
        11.22.2 Dendreon Corporation Overview
        11.22.3 Dendreon Corporation Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.22.4 Dendreon Corporation Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.22.5 Dendreon Corporation Recent Developments
    11.23 Agilent Technologies Inc.
        11.23.1 Agilent Technologies Inc. Corporation Information
        11.23.2 Agilent Technologies Inc. Overview
        11.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.23.4 Agilent Technologies Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.23.5 Agilent Technologies Inc. Recent Developments
    11.24 Agenus Inc.
        11.24.1 Agenus Inc. Corporation Information
        11.24.2 Agenus Inc. Overview
        11.24.3 Agenus Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.24.4 Agenus Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.24.5 Agenus Inc. Recent Developments
    11.25 Enzo Biochem, Inc.
        11.25.1 Enzo Biochem, Inc. Corporation Information
        11.25.2 Enzo Biochem, Inc. Overview
        11.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.25.4 Enzo Biochem, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.25.5 Enzo Biochem, Inc. Recent Developments
    11.26 Lonza Group
        11.26.1 Lonza Group Corporation Information
        11.26.2 Lonza Group Overview
        11.26.3 Lonza Group Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.26.4 Lonza Group Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.26.5 Lonza Group Recent Developments
    11.27 Bio-Rad Laboratories, Inc.
        11.27.1 Bio-Rad Laboratories, Inc. Corporation Information
        11.27.2 Bio-Rad Laboratories, Inc. Overview
        11.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.27.4 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.27.5 Bio-Rad Laboratories, Inc. Recent Developments
    11.28 Avantor, Inc.
        11.28.1 Avantor, Inc. Corporation Information
        11.28.2 Avantor, Inc. Overview
        11.28.3 Avantor, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.28.4 Avantor, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.28.5 Avantor, Inc. Recent Developments
    11.29 Spring Bank Pharmaceuticals, Inc.
        11.29.1 Spring Bank Pharmaceuticals, Inc. Corporation Information
        11.29.2 Spring Bank Pharmaceuticals, Inc. Overview
        11.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.29.4 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.29.5 Spring Bank Pharmaceuticals, Inc. Recent Developments
    11.30 Ferring Pharmaceuticals
        11.30.1 Ferring Pharmaceuticals Corporation Information
        11.30.2 Ferring Pharmaceuticals Overview
        11.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.30.4 Ferring Pharmaceuticals Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.30.5 Ferring Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Immuno-oncology Drugs Industry Chain Analysis
    12.2 Immuno-oncology Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Immuno-oncology Drugs Production Mode & Process
    12.4 Immuno-oncology Drugs Sales and Marketing
        12.4.1 Immuno-oncology Drugs Sales Channels
        12.4.2 Immuno-oncology Drugs Distributors
    12.5 Immuno-oncology Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Immuno-oncology Drugs Industry Trends
    13.2 Immuno-oncology Drugs Market Drivers
    13.3 Immuno-oncology Drugs Market Challenges
    13.4 Immuno-oncology Drugs Market Restraints
14 Key Findings in The Global Immuno-oncology Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Immuno-oncology Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Immune Checkpoint Inhibitors
    Table 3. Major Manufacturers of Immune System Modulators
    Table 4. Major Manufacturers of Cancer Vaccines
    Table 5. Major Manufacturers of Oncolytic Virus
    Table 6. Major Manufacturers of Others
    Table 7. Global Immuno-oncology Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Immuno-oncology Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Immuno-oncology Drugs Sales by Region (2017-2022) & (K Units)
    Table 10. Global Immuno-oncology Drugs Sales Market Share by Region (2017-2022)
    Table 11. Global Immuno-oncology Drugs Sales by Region (2023-2028) & (K Units)
    Table 12. Global Immuno-oncology Drugs Sales Market Share by Region (2023-2028)
    Table 13. Global Immuno-oncology Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Immuno-oncology Drugs Revenue Market Share by Region (2017-2022)
    Table 15. Global Immuno-oncology Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Immuno-oncology Drugs Revenue Market Share by Region (2023-2028)
    Table 17. Global Immuno-oncology Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Immuno-oncology Drugs Sales Share by Manufacturers (2017-2022)
    Table 19. Global Immuno-oncology Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Immuno-oncology Drugs Revenue Share by Manufacturers (2017-2022)
    Table 21. Immuno-oncology Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Immuno-oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Immuno-oncology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Drugs as of 2021)
    Table 24. Immuno-oncology Drugs Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Immuno-oncology Drugs Product Offered
    Table 26. Date of Manufacturers Enter into Immuno-oncology Drugs Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
    Table 29. Global Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
    Table 30. Global Immuno-oncology Drugs Sales Share by Type (2017-2022)
    Table 31. Global Immuno-oncology Drugs Sales Share by Type (2023-2028)
    Table 32. Global Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Immuno-oncology Drugs Revenue Share by Type (2017-2022)
    Table 35. Global Immuno-oncology Drugs Revenue Share by Type (2023-2028)
    Table 36. Immuno-oncology Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Immuno-oncology Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
    Table 39. Global Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
    Table 40. Global Immuno-oncology Drugs Sales Share by Application (2017-2022)
    Table 41. Global Immuno-oncology Drugs Sales Share by Application (2023-2028)
    Table 42. Global Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Immuno-oncology Drugs Revenue Share by Application (2017-2022)
    Table 45. Global Immuno-oncology Drugs Revenue Share by Application (2023-2028)
    Table 46. Immuno-oncology Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Immuno-oncology Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
    Table 49. North America Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
    Table 50. North America Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
    Table 53. North America Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
    Table 54. North America Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Immuno-oncology Drugs Sales by Country (2017-2022) & (K Units)
    Table 57. North America Immuno-oncology Drugs Sales by Country (2023-2028) & (K Units)
    Table 58. North America Immuno-oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Immuno-oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Immuno-oncology Drugs Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Immuno-oncology Drugs Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Immuno-oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Immuno-oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Immuno-oncology Drugs Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Immuno-oncology Drugs Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Immuno-oncology Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Immuno-oncology Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Immuno-oncology Drugs Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Immuno-oncology Drugs Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Immuno-oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Immuno-oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Immuno-oncology Drugs Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Immuno-oncology Drugs Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Immuno-oncology Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Immuno-oncology Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Immuno-oncology Drugs Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Immuno-oncology Drugs Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Immuno-oncology Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Immuno-oncology Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Immuno-oncology Drugs Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Immuno-oncology Drugs Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Immuno-oncology Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Immuno-oncology Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Amgen, Inc Corporation Information
    Table 109. Amgen, Inc Description and Major Businesses
    Table 110. Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Amgen, Inc Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Amgen, Inc Recent Developments
    Table 113. AstraZeneca, Plc Corporation Information
    Table 114. AstraZeneca, Plc Description and Major Businesses
    Table 115. AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. AstraZeneca, Plc Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. AstraZeneca, Plc Recent Developments
    Table 118. Bristol-Myers Squibb Corporation Information
    Table 119. Bristol-Myers Squibb Description and Major Businesses
    Table 120. Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Bristol-Myers Squibb Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Bristol-Myers Squibb Recent Developments
    Table 123. Celgene Corporation Corporation Information
    Table 124. Celgene Corporation Description and Major Businesses
    Table 125. Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Celgene Corporation Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Celgene Corporation Recent Developments
    Table 128. Eli Lilly and Company Corporation Information
    Table 129. Eli Lilly and Company Description and Major Businesses
    Table 130. Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. Eli Lilly and Company Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Eli Lilly and Company Recent Developments
    Table 133. Merck & Co. Corporation Information
    Table 134. Merck & Co. Description and Major Businesses
    Table 135. Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Merck & Co. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Merck & Co. Recent Developments
    Table 138. Hoffmann-La Roche AG Corporation Information
    Table 139. Hoffmann-La Roche AG Description and Major Businesses
    Table 140. Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Hoffmann-La Roche AG Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Hoffmann-La Roche AG Recent Developments
    Table 143. Johnson & Johnson Corporation Information
    Table 144. Johnson & Johnson Description and Major Businesses
    Table 145. Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. Johnson & Johnson Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Johnson & Johnson Recent Developments
    Table 148. Novartis International AG Corporation Information
    Table 149. Novartis International AG Description and Major Businesses
    Table 150. Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Novartis International AG Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Novartis International AG Recent Developments
    Table 153. AbbVie, Inc. Corporation Information
    Table 154. AbbVie, Inc. Description and Major Businesses
    Table 155. AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. AbbVie, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. AbbVie, Inc. Recent Developments
    Table 158. Pfizer Inc. Corporation Information
    Table 159. Pfizer Inc. Description and Major Businesses
    Table 160. Pfizer Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 161. Pfizer Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Pfizer Inc. Recent Developments
    Table 163. Sanofi S.A. Corporation Information
    Table 164. Sanofi S.A. Description and Major Businesses
    Table 165. Sanofi S.A. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 166. Sanofi S.A. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Sanofi S.A. Recent Developments
    Table 168. EMD Serono, Inc. Corporation Information
    Table 169. EMD Serono, Inc. Description and Major Businesses
    Table 170. EMD Serono, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 171. EMD Serono, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. EMD Serono, Inc. Recent Developments
    Table 173. Gilead Sciences Inc. Corporation Information
    Table 174. Gilead Sciences Inc. Description and Major Businesses
    Table 175. Gilead Sciences Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 176. Gilead Sciences Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Gilead Sciences Inc. Recent Developments
    Table 178. Prometheus Therapeutics & Diagnostics Corporation Information
    Table 179. Prometheus Therapeutics & Diagnostics Description and Major Businesses
    Table 180. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 181. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Prometheus Therapeutics & Diagnostics Recent Developments
    Table 183. Aduro BioTech Corporation Information
    Table 184. Aduro BioTech Description and Major Businesses
    Table 185. Aduro BioTech Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 186. Aduro BioTech Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Aduro BioTech Recent Developments
    Table 188. Galena Biopharma Corporation Information
    Table 189. Galena Biopharma Description and Major Businesses
    Table 190. Galena Biopharma Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 191. Galena Biopharma Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 192. Galena Biopharma Recent Developments
    Table 193. Bavarian Nordic Corporation Information
    Table 194. Bavarian Nordic Description and Major Businesses
    Table 195. Bavarian Nordic Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 196. Bavarian Nordic Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 197. Bavarian Nordic Recent Developments
    Table 198. Celldex Therapeutics Corporation Information
    Table 199. Celldex Therapeutics Description and Major Businesses
    Table 200. Celldex Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 201. Celldex Therapeutics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 202. Celldex Therapeutics Recent Developments
    Table 203. ImmunoCellular Therapeutics Corporation Information
    Table 204. ImmunoCellular Therapeutics Description and Major Businesses
    Table 205. ImmunoCellular Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 206. ImmunoCellular Therapeutics Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 207. ImmunoCellular Therapeutics Recent Developments
    Table 208. Incyte Corporation Information
    Table 209. Incyte Description and Major Businesses
    Table 210. Incyte Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 211. Incyte Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 212. Incyte Recent Developments
    Table 213. Dendreon Corporation Corporation Information
    Table 214. Dendreon Corporation Description and Major Businesses
    Table 215. Dendreon Corporation Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 216. Dendreon Corporation Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 217. Dendreon Corporation Recent Developments
    Table 218. Agilent Technologies Inc. Corporation Information
    Table 219. Agilent Technologies Inc. Description and Major Businesses
    Table 220. Agilent Technologies Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 221. Agilent Technologies Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 222. Agilent Technologies Inc. Recent Developments
    Table 223. Agenus Inc. Corporation Information
    Table 224. Agenus Inc. Description and Major Businesses
    Table 225. Agenus Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 226. Agenus Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 227. Agenus Inc. Recent Developments
    Table 228. Enzo Biochem, Inc. Corporation Information
    Table 229. Enzo Biochem, Inc. Description and Major Businesses
    Table 230. Enzo Biochem, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 231. Enzo Biochem, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 232. Enzo Biochem, Inc. Recent Developments
    Table 233. Lonza Group Corporation Information
    Table 234. Lonza Group Description and Major Businesses
    Table 235. Lonza Group Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 236. Lonza Group Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 237. Lonza Group Recent Developments
    Table 238. Bio-Rad Laboratories, Inc. Corporation Information
    Table 239. Bio-Rad Laboratories, Inc. Description and Major Businesses
    Table 240. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 241. Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 242. Bio-Rad Laboratories, Inc. Recent Developments
    Table 243. Avantor, Inc. Corporation Information
    Table 244. Avantor, Inc. Description and Major Businesses
    Table 245. Avantor, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 246. Avantor, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 247. Avantor, Inc. Recent Developments
    Table 248. Spring Bank Pharmaceuticals, Inc. Corporation Information
    Table 249. Spring Bank Pharmaceuticals, Inc. Description and Major Businesses
    Table 250. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 251. Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 252. Spring Bank Pharmaceuticals, Inc. Recent Developments
    Table 253. Ferring Pharmaceuticals Corporation Information
    Table 254. Ferring Pharmaceuticals Description and Major Businesses
    Table 255. Ferring Pharmaceuticals Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 256. Ferring Pharmaceuticals Immuno-oncology Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 257. Ferring Pharmaceuticals Recent Developments
    Table 258. Key Raw Materials Lists
    Table 259. Raw Materials Key Suppliers Lists
    Table 260. Immuno-oncology Drugs Distributors List
    Table 261. Immuno-oncology Drugs Customers List
    Table 262. Immuno-oncology Drugs Market Trends
    Table 263. Immuno-oncology Drugs Market Drivers
    Table 264. Immuno-oncology Drugs Market Challenges
    Table 265. Immuno-oncology Drugs Market Restraints
    Table 266. Research Programs/Design for This Report
    Table 267. Key Data Information from Secondary Sources
    Table 268. Key Data Information from Primary Sources
List of Figures
    Figure 1. Immuno-oncology Drugs Product Picture
    Figure 3. Global Immuno-oncology Drugs Market Share by Type in 2021 & 2028
    Figure 3. Immune Checkpoint Inhibitors Product Picture
    Figure 4. Immune System Modulators Product Picture
    Figure 5. Cancer Vaccines Product Picture
    Figure 6. Oncolytic Virus Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Immuno-oncology Drugs Market Share by Application in 2021 & 2028
    Figure 9. Hospitals
    Figure 10. Clinics
    Figure 11. Ambulatory Surgical Centers
    Figure 12. Immuno-oncology Drugs Report Years Considered
    Figure 13. Global Immuno-oncology Drugs Sales 2017-2028 (K Units)
    Figure 14. Global Immuno-oncology Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Immuno-oncology Drugs Revenue 2017-2028 (US$ Million)
    Figure 16. Global Immuno-oncology Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Immuno-oncology Drugs Sales Market Share by Region (2017-2022)
    Figure 18. Global Immuno-oncology Drugs Sales Market Share by Region (2023-2028)
    Figure 19. North America Immuno-oncology Drugs Sales YoY (2017-2028) & (K Units)
    Figure 20. North America Immuno-oncology Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Immuno-oncology Drugs Sales YoY (2017-2028) & (K Units)
    Figure 22. Europe Immuno-oncology Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Immuno-oncology Drugs Sales YoY (2017-2028) & (K Units)
    Figure 24. Asia-Pacific Immuno-oncology Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Immuno-oncology Drugs Sales YoY (2017-2028) & (K Units)
    Figure 26. Latin America Immuno-oncology Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Immuno-oncology Drugs Sales YoY (2017-2028) & (K Units)
    Figure 28. Middle East & Africa Immuno-oncology Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Immuno-oncology Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Immuno-oncology Drugs in the World: Market Share by Immuno-oncology Drugs Revenue in 2021
    Figure 31. Global Immuno-oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Immuno-oncology Drugs Sales Market Share by Type (2017-2028)
    Figure 33. Global Immuno-oncology Drugs Revenue Market Share by Type (2017-2028)
    Figure 34. Global Immuno-oncology Drugs Sales Market Share by Application (2017-2028)
    Figure 35. Global Immuno-oncology Drugs Revenue Market Share by Application (2017-2028)
    Figure 36. North America Immuno-oncology Drugs Sales Market Share by Type (2017-2028)
    Figure 37. North America Immuno-oncology Drugs Revenue Market Share by Type (2017-2028)
    Figure 38. North America Immuno-oncology Drugs Sales Market Share by Application (2017-2028)
    Figure 39. North America Immuno-oncology Drugs Revenue Market Share by Application (2017-2028)
    Figure 40. North America Immuno-oncology Drugs Sales Share by Country (2017-2028)
    Figure 41. North America Immuno-oncology Drugs Revenue Share by Country (2017-2028)
    Figure 42. U.S. Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Immuno-oncology Drugs Sales Market Share by Type (2017-2028)
    Figure 45. Europe Immuno-oncology Drugs Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Immuno-oncology Drugs Sales Market Share by Application (2017-2028)
    Figure 47. Europe Immuno-oncology Drugs Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Immuno-oncology Drugs Sales Share by Country (2017-2028)
    Figure 49. Europe Immuno-oncology Drugs Revenue Share by Country (2017-2028)
    Figure 50. Germany Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. France Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Immuno-oncology Drugs Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Immuno-oncology Drugs Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Immuno-oncology Drugs Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Immuno-oncology Drugs Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Immuno-oncology Drugs Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Immuno-oncology Drugs Revenue Share by Region (2017-2028)
    Figure 61. China Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. India Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Immuno-oncology Drugs Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Immuno-oncology Drugs Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Immuno-oncology Drugs Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Immuno-oncology Drugs Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Immuno-oncology Drugs Sales Share by Country (2017-2028)
    Figure 76. Latin America Immuno-oncology Drugs Revenue Share by Country (2017-2028)
    Figure 77. Mexico Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Immuno-oncology Drugs Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Immuno-oncology Drugs Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Immuno-oncology Drugs Sales Market Share by Application (2017-2028)_x000D
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte
Dendreon Corporation
Agilent Technologies Inc.
Agenus Inc.
Enzo Biochem, Inc.
Lonza Group
Bio-Rad Laboratories, Inc.
Avantor, Inc.
Spring Bank Pharmaceuticals, Inc.
Ferring Pharmaceuticals
Frequently Asked Questions
Immuno-oncology Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immuno-oncology Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immuno-oncology Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

In-mold Label

In-mold Label market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More

Lighting Fixture

Lighting Fixture market is segmented by Type and by Application. Players, stakeholders, and other ... Read More